Davis Hugh M. bought ACRS
February 2, 2026 · Form 4 insider transaction
Davis Hugh M. bought 96,100 shares of Aclaris Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
96,100
Price
$0.00
Total value
N/A
InsiderDavis Hugh M.
RoleOfficer, Director
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateFebruary 2, 2026
Filing dateFebruary 6, 2026
Shares owned after96,100
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.; The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.